U.S. government taps GlaxoSmithKline for new antibiotics
LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual thr...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/jxyN7byt3WA/story01.htm
No comments:
Post a Comment